Enogen is a CDMO of peptides based in China (Zhejiang). Direct manufacturer. Founded 2015. Key products include Semaglutide API, Tirzepatide API.
China peptide API manufacturer and CDMO. NMPA, US FDA, EU EDQM, Korea MFDS certified. 80+ patents. 20KG per batch semaglutide capability. Supplies pharmaceutical partners globally.
Enogen is listed as a CDMO in the peptide supply chain, serving Asia markets from China (Zhejiang). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is based on publicly available information and cross-referenced against industry databases. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.